Association between HLA Class II Alleles/Haplotypes and Genomic Ancestry in Brazilian Patients with Type 1 Diabetes: A Nationwide Exploratory Study

Genes (Basel). 2023 Apr 27;14(5):991. doi: 10.3390/genes14050991.

Abstract

We aimed to identify HLA-DRB1, -DQA1, and -DQB1 alleles/haplotypes associated with European, African, or Native American genomic ancestry (GA) in admixed Brazilian patients with type 1 diabetes (T1D). This exploratory nationwide study enrolled 1599 participants. GA percentage was inferred using a panel of 46 ancestry informative marker-insertion/deletion. Receiver operating characteristic curve analysis (ROC) was applied to identify HLA class II alleles related to European, African, or Native American GA, and showed significant (p < 0.05) accuracy for identifying HLA risk alleles related to European GA: for DRB1*03:01, the area under the curve was (AUC) 0.533; for DRB1*04:01 AUC = 0.558, for DRB1*04:02 AUC = 0.545. A better accuracy for identifying African GA was observed for the risk allele DRB1*09:01AUC = 0.679 and for the protective alleles DRB1*03:02 AUC = 0.649, DRB1*11:02 AUC = 0.636, and DRB1*15:03 AUC = 0.690. Higher percentage of European GA was observed in patients with risk haplotypes (p < 0.05). African GA percentage was higher in patients with protective haplotypes (p < 0.05). Risk alleles and haplotypes were related to European GA and protective alleles/haplotypes to African GA. Future studies with other ancestry markers are warranted to fill the gap in knowledge regarding the genetic origin of T1D in highly admixed populations such as that found in Brazil.

Keywords: HLA; admixed; ethnicity; genomic ancestry; human leukocyte antigen; type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Brazil
  • Diabetes Mellitus, Type 1* / genetics
  • Genomics
  • Haplotypes
  • Humans

Grants and funding

This work was supported by FAPERJ (Fundação do Amparo à Pesquisa do Estado do Rio de Janeiro) [grant numbers E 26/110.170/2013] and CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico do Brasil) [grant number 563753/2010-2]. L.C.P is also supported by FAPERJ (CNE) and CNPq. L.C.P. was supported by FAPERJ (Fundação do Amparo à Pesquisa do Estado do Rio de Janeiro) (grant numbers E-26/202.683/2019 and E-26/200.530/20123) and CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico do Brasil) (grant number 309881/2018-8).